Abstract:pRb and its family members p130 and p107 regulate cell cycle progression and direct G1/S transition in mammalian cells through interaction with the transcription factor E2F. Phosphatidylinositol 3-kinase (PI3K) is an essential component of growth factor-regulated pathways and plays a crucial role in the regulation of cellular proliferation and differentiation. It has been demonstrated that PI3K can regulate cell cycle progression via Akt-mediated pathway. However, the possible interactions between PI3K and Rb pathways remain to be defined. It was reported that the unique 24-amino-acid N-terminal end of the p55 regulatory subunits of PI3K is an Rb-binding domain and affects Rb action or Rb-E2F interaction. The 24 N-terminal amino acids of p55 gamma encoded by a cDNA construct could compete with the endogenous p55 gamma for binding to Rb, which influences Rb-mediated signaling and blocks cell cycle progression. In the current study, we investigated the effects of this 24-peptide on cell proliferation in human gastric C, carcinoma MKN-28 cells by means of cell cycle analysis, BrdU incorporation. and determining the levels of cell cycle regulatory molecule expression. Our results showed that p55 gamma PI3K and the Rb family members p130 and p107 exist in MKN-28 cells, while the p110PI3K was not detected. Moreover, p55 gamma PI3K was found binding to p130/p107 in these cells. We demonstrated that the introduction of the plasmid N24p55-GFP (harboring the cDNA for the 24 N-terminal amino acids of p55 gamma) into MKN-28 cells caused cell cycle arrest at G1. Furthermore, we showed that the overexpression of the 24-peptide in MKN-28 cells decreased the population of cells incorporating BrdU and reduced the levels of cyclin D1 and cyclin A. These observations suggest that PI3K can regulate cell cycle progression and cell proliferation in human gastric tumor cells via Rb-mediated pathway, and that this effect of PI3K is mediated through a direct association with Rb via the N-terminal end of its p55 kDa regulatory subunits and modulating Rb-E2F interactions.Taken together with previous studies, our data provide a L, new therapeutic target in human stomach cancer. Strategies targeting PI3K signal transduction or the association of PI3K C C with Rb, or regulating PI3K-Rb interactions could be employed for gene therapy or chemotherapy of gastric cancer C, and other tumors.

Inhibition of plk1 Expression Leads to Increased CyclinB/cdc2 Complex Activity in Gastric Cancer Cells

Mitosis Arrest Caused by Inhibition of PLK1 Expression in Gastric Cancer MKN45 Cells

Inhibition of Plk-1 gene expression enhences 5-Fu and CDDP induced apoptosis of gastric cancer cells

[Study of Growth Inhibition of Gastric Cancer Cells by Srna Targeting Polo Like Kinase 1 in Vitro and Vivo].

Inhibitory Effect of Polo-like Kinase 1 Depletion on Mitosis and Apoptosis of Gastric Cancer Cells

Effects of Lncrna ANRIL-knockdown on the Proliferation, Apoptosis and Cell Cycle of Gastric Cancer Cells.

Phospholipase C Delta 1 is a Novel 3p22.3 Tumor Suppressor Involved in Cytoskeleton Organization, with Its Epigenetic Silencing Correlated with High-Stage Gastric Cancer

Involvement of Polo-like Kinase 1 (plk1) in Quiescence Regulation of Cancer Stem-Like Cells of the Gastric Cancer Cell Lines

Involvement of Polo-like Kinase 1 (plk1) in Mitotic Arrest by Inhibition of Mitogen-activated Protein Kinase-Extracellular Signal-regulated Kinase-Ribosomal S6 Kinase 1

Silencing of polo-like kinase 2 increases cell proliferation and decreases apoptosis in SGC-7901 gastric cancer cells.

Significance of Polo Like Kinase1 and Protein Expression in Gastric Carcinomas

Polo Like Kinase 1 Expression and Prognostic Value in Gastric Carcinomas

POLO-LIKE KINASE1 GENE EXPRESSION AND ITS CLINICOPATHOLOGICAL SIGNIFICANCE IN GASTRIC CARCINOMA

Involvement of Polo-like Kinase 1 (plk1) in Mitotic Arrest by Inhibition of Mitogen-activated Protein Kinase-Extracellular Signal-regulated Kinase-Ribosomal S6 Kinase 1 (MEK-ERK-RSK1) Cascade*

Study on folate deficiency and Polo-like kinase 1 (PLK-1) siRNA in synergistically inhibiting the growtho f gsa tric carcinoma cell lines

Correction: Hormonal Induction of Polo-Like Kinases (plks) and Impact of Plk2 on Cell Cycle Progression in the Rat Ovary

The Expression of Plk-1 in Cervical Carcinoma: A Possible Target for Enhancing Chemosensitivity

Overexpiression Of The N-Terminal End Of The P55 Gamma Regulatory Subunit Of Phosphatidylinositol 3-Kinase Blocks Cell Cycle Progression In Gastric Carcinoma Cells

Experimental Study on Silencing the KLK12 Expression by Sirna to Inhibit the Growth of Gastric Cancer Cells

Efficient inhibition of human colorectal carcinoma growth by RNA interference targeting polo-like kinase 1 in vitro and in vivo.

Overexpression of PlK-1 gene effects of PlK-1 gene on the chemotherapeutic sensitivity of pancreatic carcinoma cell line AsPC-1 response to gemcitabine